Niki BioSolutions, Inc. (NIKI) Accounts Payables (2017 - 2025)

Niki BioSolutions' (NIKI) quarterly Accounts Payables came in at $673396.0 in Q4 2025, up 12.78% on a QoQ basis from $597096.0 in Q3 2025.

Niki BioSolutions, Inc. (NIKI) Accounts Payables (2017 - 2025) Analysis & Trends

Niki BioSolutions (NIKI) has 9 years of Accounts Payables data on file, last reported at $673396.0 in Q4 2025.

Quarterly Accounts Payables changed N/A year-over-year to $673396.0 in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $673396.0 (changed N/A YoY) and the FY2025 annual result came in at $1.1 million, up 16.67% from the prior year.
Accounts Payables advanced to $673396.0 in Q4 2025, from $597096.0 in the prior quarter.
In the past five years, Accounts Payables ranged from a high of $6.2 million in Q4 2022 to a low of $148648.0 in Q2 2024.
A 5-year average of $2.3 million and a median of $1.5 million in 2023 frame the typical range for Accounts Payables.
Annual changes were most pronounced in 2023 — Accounts Payables sank 78.45% — and 2025, when it soared 55.98%.
Tracing NIKI's Accounts Payables over 5 years: stood at $4.2 million in 2021, then soared by 47.79% to $6.2 million in 2022, then tumbled by 69.28% to $1.9 million in 2023, then plunged by 92.15% to $148648.0 in 2024, then jumped by 353.01% to $673396.0 in 2025.
The last three Accounts Payables figures came in at $673396.0 (Q4 2025), $597096.0 (Q3 2025), and $231858.0 (Q2 2025), per Business Quant data.

Download Data